MarketBeat
30 Jul 2026, 23:04 UTC · 3d ago
Fulgent Genetics Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
30 Jul 2026, 23:04 UTC · 3d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Fulgent lowered its full-year 2026 revenue guidance to $330M–$340M from a previous target of $350M. — Direct reduction in top-line expectations typically triggers a negative valuation adjustment.
-0.60The company's largest customer is moving testing capabilities in-house, leading to a sequential revenue drop of $4.6M and expected further declines in H2. — Loss of a major client represents a structural decay in revenue that may not be fully offset by acquisitions.
-0.50A transition to a new billing system caused lower collection rates, delaying revenue recognition and compressing GAAP gross margins to 30.1%. — Operational inefficiency in billing creates short-term cash flow uncertainty and margin pressure.
-0.30Continue reading
6 related stories
Top 2 movers · tap to explore
Fulgent reported Q2 2026 revenue of $85.4 million, a 20% sequential increase driven by the integration of Bako Diagnostics and StrataDx. — Successful inorganic growth provides a buffer against legacy business declines.
+0.30The company maintains a strong liquidity position with $551.5 million in cash, restricted cash, and marketable securities. — Substantial cash reserves mitigate insolvency risk and provide a cushion for operating losses.
+0.20Which stocks this story touches
The company lowered its full-year revenue guidance, reported a net loss, and is facing headwinds from billing system issues and a major customer moving testing in-house.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
7h ago
